Cyclopamine, an inhibitor of the SHH pathway, was also proved effective in reducing SOX2 expression and inducing cytotoxicity in in vitro studies, but unlike rapamycin, its combination with TMZ did not increase the sensitivity of glioma cells to chemotherapy (16). The gene discussed is SHH; the disease is glioma.